William Conkling

William Conkling

Director/Board Member at IDT CORPORATION

Net worth: 2 M $ as of 30/06/2026

54 year
Health Technology
Consumer Services
Communications

Profile

William Conkling is currently Director at Day Three Labs, Inc. and Cornerstone Pharmaceuticals, Inc. Mr. Conkling is also Independent Director at IDT Corp.
starting in 2026 and Chief Commercial Officer at Protara Therapeutics, Inc. starting in 2025.
Formerly, Mr. Conkling was President & Chief Executive Officer at Rafael Holdings, Inc. from 2023 to 2025, Independent Director at Cyclo Therapeutics, Inc. from 2023 to 2025, and Vice President-Sales, Marketing & Market Access at Immunomedics, Inc. from 2018 to 2021.
Education includes undergraduate studies at Fordham University and an MBA from The Leonard N Stern School of Business, conferred in 1998.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/11/2025 490,770 ( 0.96% ) 2 M $ 30/06/2026
02/06/2026 69,992 ( 0.12% ) 267 369 $ 30/06/2026
09/06/2026 673 ( 0% ) 39 142 $ 30/06/2026

William Conkling active positions

CompaniesPositionStart
PROTARA THERAPEUTICS, INC. Corporate Officer/Principal 02/06/2025
IDT CORPORATION Director/Board Member 09/06/2026
Director/Board Member -
Director/Board Member -

Former positions of William Conkling

CompaniesPositionEnd
RAFAEL HOLDINGS, INC. Chief Executive Officer 31/05/2025
CYCLO THERAPEUTICS, INC. Director/Board Member 25/03/2025
IMMUNOMEDICS, INC. Sales & Marketing 01/03/2021
See the detail of William Conkling's experience

Training of William Conkling

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Communications

Commercial Services

Consumer Services

Consumer Services

Finance

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. William Conkling